1 03, 2025 Veronica Agostinelli et al., The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy adlitterio663392025-03-01T15:12:42+01:00 Mehr erfahren
18 02, 2025 HAL?M ÖZÇEV?K ET AL., Genetic mutations and prognostic indicators in differentiated thyroid cancer: a molecular perspective adlitterio663392025-02-18T15:21:35+01:00 Mehr erfahren
15 02, 2025 Robrto Montalti et al., Prognostic role of postoperative persistence of ctDNA molecular signature after liver resection for colorectal liver metastases: Preliminary results from a prospective study adlitterio663392025-02-15T15:19:51+01:00 Mehr erfahren
13 02, 2025 Seda Er Özilhan et al., Correlation of PD-L1 and HIF-1 Alpha Expression with KRAS Mutation and Clinicopathological Parameters in Non-Small Cell Lung Cancer adlitterio663392025-02-13T15:14:58+01:00 Mehr erfahren
27 01, 2025 Elisabetta Maffei et al., Suitability of Different Cytological Preparations for Molecular Analysis of Advanced Non-Small Cell Lung Cancers adlitterio663392025-01-27T15:07:22+01:00 Mehr erfahren
2 01, 2025 Jessica Lucchetti et al., Aflibercept-Based and Bevacizumab-Based Second Line Regimens in Patients with Metastatic Colorectal Cancer: Propensity Score Weighted-Analysis from a Multicenter Cohort adlitterio663392025-01-02T14:43:18+01:00 Mehr erfahren
19 11, 2024 Rosanna Squitti et al., Copper dysmetabolism is connected to epithelial-mesenchymal transition: A pilot study in colorectal cancer patients adlitterio663392024-11-19T12:58:51+01:00 Mehr erfahren
15 11, 2024 Krishnamurthy Hari et al., Classification of colorectal cancer patients based on serum micronutrients: An exploratory investigation adlitterio663392025-01-02T13:02:14+01:00 Mehr erfahren
30 10, 2024 Laura Simone et al., Tailored treatment and clinical management for DPYD compound heterozygous: a multidisciplinary teamwork adlitterio663392024-10-30T11:30:50+01:00 Mehr erfahren
28 10, 2024 Pasquale Pisapia et al., The relevance of the reference range for EGFR testing in non-small cell lung cancer patients adlitterio663392024-10-28T11:27:03+01:00 Mehr erfahren
